Cargando…
Usefulness of CD109 expression as a prognostic biomarker in patients with cancer: A systematic review and meta-analysis
BACKGROUND: It has been revealed that CD109 expression is associated with prognosis in cancer patients, but it remains unclear thus far. Therefore, we performed a meta-analysis in the present study for a better assessment of the prognostic role of CD109 expression in cancer patients. METHODS: Eligib...
Autores principales: | Koh, Hyun Min, Lee, Hyun Ju, Kim, Dong Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982172/ https://www.ncbi.nlm.nih.gov/pubmed/33725975 http://dx.doi.org/10.1097/MD.0000000000025006 |
Ejemplares similares
-
Prognostic significance of macrophage migration inhibitory factor expression in cancer patients: A systematic review and meta-analysis
por: Koh, Hyun Min, et al.
Publicado: (2020) -
Prognostic role of S100A9 expression in patients with clear cell renal cell carcinoma
por: Koh, Hyun Min, et al.
Publicado: (2019) -
The relationship between hepatoma-derived growth factor and prognosis in non-small cell lung cancer: A systematic review and meta-analysis
por: Koh, Hyun Min, et al.
Publicado: (2020) -
Prognostic and clinicopathological value of CD90 expression in cancer patients: a systematic review and meta-analysis
por: Koh, Hyun Min, et al.
Publicado: (2021) -
Prognostic value of CD44v9 expression in human cancers: A systematic review and meta-analysis
por: Zeng, Li, et al.
Publicado: (2020)